Investing Profile

Dylan Morris

VCInvestor
Managing Director at Insight Partners
insightpartners.com/team/dyla...San Francisco Bay Area
Photo of Dylan Morris, Managing Director at Insight Partners
cb
Insight Partners Managing Director
$10.0M - $350.0M
$25.0M
14
$20B
CompanyStageDateRound SizeTotal Raised
Superluminal Medicines
Series ASep 2024$120M
$150M
Co-investors: Andrew Levin (RA Capital)
Gameto
Series BMay 2024$33M
Series UnknownSep 2022$17M
$73M
Co-investors: Dan Rose (Coatue), Steve Jurvetson (Future Ventures), Maryanna Saenko (Future Ventures), Robert Nelsen (ARCH Venture Partners), Jack Abraham (Atomic), Laura Stoppel (RA Capital), Dusan Perovic (Two Sigma Ventures), Peter Kolchinsky (RA Capital), Anne Wojcicki
Profluent Bio
Series UnknownMar 2024$35M
SeedAug 2022$9M
$44M
Co-investors: Fraser Kelton (Spark Capital), Nathan Benaich (Air Street Capital)
Unlearn.AI
Series CFeb 2024$50M
Series BApr 2022$50M
$120M
Co-investors: Francisco Gimenez (8VC), Rob Toews (Radical Ventures), Jack Boren
Capacity Bio
Series AMar 2023$35M
$35M
Co-investors: Taro Inaba (Remiges Ventures), Cristina Ghenoiu (RA Capital)
Switch Therapeutics
Series AMar 2023$52M
$52M
Co-investors: Hiroki Takai (Global Brain)
ImmuneBridge
SeedJan 2023$12M
$12M
Co-investors: Cheryl Zimberlin (M Ventures (Merck))
DEM BioPharma
Series AJun 2022$70M
$70M
Co-investors: Hiromichi Kimura (Astellas Venture Management), Christoph Westphal (Longwood Fund), Dan Janney (Alta Partners)